This site runs best with JavaScript enabled
Proton Logo

Latest news from ProtonDx

ProtonDx welcomes new CFO, Ann Wong, to drive scale-up and commercial expansion

Thu, March 16th 2023

• Ann Wong brings extensive experience of scaling organisations and leading finance operations

Read article

Dragonfly Respiratory Panel reliably identifies five most common causes of respiratory infections, joins list of UK approved diagnostic products

Mon, February 6th 2023

• Rapid molecular point-of-care diagnostic system reliably detects SARS-CoV-2, Flu A, Flu B, RSV and Human Rhinovirus • Clinical test results for CTDA validation achieved 100% sensitivity and 100% specificity • UK approval follows CE-IVD mark

Read article

ProtonDx and Katalyst announce strategic partnership to distribute Dragonfly in vitro diagnostic

Mon, January 9th 2023

• Exclusive rights to distribute CE-IVD marked Dragonfly diagnostic system in key client segments. • Dragonfly System able to detect five common respiratory pathogens at once.

Read article

ProtonDx Revs Up European Commercial Expansion with New Head of Sales

Thu, December 15th 2022

• Leigh Howes brings more than 20 years diagnostics sector experience • Track record of commercial success across Europe

Read article

The respiratory infection season – multiple infections, multiple detection

Mon, December 12th 2022

Assistant Professor Jesus Rodriguez Manzano, Co-Founder and CSO at ProtonDx, and Deputy Director of the Centre for Antimicrobial Optimisation (CAMO) at Imperial College, shares his views on the current threat of a ‘tripledemic’ that looms over the Northern hemisphere, including many parts of Europe.

Read article

ProtonDx awarded £365,000 Defra and Innovate UK grant to develop Porcine Lung Disease diagnostic

Fri, September 23rd 2022

• Grant to develop automated, rapid point-of-need diagnostic to provide a sustainable and resilient revolution in detection and diagnosis of Porcine Respiratory Disease Complex (PRDC) • Working in collaboration with Imperial College, farmers and industry experts to help address the global issue of rising antibiotic resistance

Read article

Diagnostics are at the heart of a global AMR solution

Wed, September 14th 2022

Opinion article: Dr Jesus Rodriguez-Manzano, Co-Founder and Chief Scientific Officer (CSO) at ProtonDx, shares his thoughts on anti-microbial resistance (AMR). He discusses what we can learn from the recent COVID‑19 pandemic, including the important role that point-of-need diagnostics can play.

Read article

ProtonDx’s Dragonfly Diagnostic System successfully deployed at the 2022 Commonwealth Games

Tue, August 30th 2022

5-in-1 Respiratory Test Panel from ProtonDx used to assess elite athletes at the 2022 Commonwealth Games

Read article

New Rapid Multi-Viral Diagnostic Kit Receives CE-IVD Mark

Tue, June 21st 2022

Dragonfly™ detects SARS-CoV-2, Flu A, Flu B, RSV and human rhinovirus without a lab. It is a cost-effective point-of-need portable diagnostic system for infectious disease now commercially available.

Read article

ProtonDx tackles malaria diagnosis

Fri, April 29th 2022

Lacewing, the futuristic lab-on-a-chip, diagnostic tool is one of eight initiatives promoted by Imperial College London to mark Malaria Day, 25 April, in order to demonstrate the College’s deep commitment to conquering malaria. Lacewing is being developed for health care applications by Imperial spin out company ProtonDx based at the College’s Translation and Innovation HUB (I-HUB), White City Campus.

Read article

Dragonfly goes Olympic

Tue, April 26th 2022

The Dragonfly Respiratory Diagnostic Panel was utilised by the Team GB clinical staff with great success to test Great Britain's athletes at the 2022 Olympic Winter Games in Beijing.

Read article

Higher risk for patients with flu and Covid-19

Mon, March 28th 2022

People infected by Covid-19 and influenza face four times the risk of requiring a ventilator and twice the risk of death. Diagnosis of which respiratory viruses are infecting the patient is crucial especially as there is no increased risk of severe illness for those with both Covid-19 and RSV or other respiratory viruses.

Read article

Lateral flow tests found wanting

Tue, March 1st 2022

Research by Imperial College London suggests that lateral flow tests miss a substantial number of COVID-19 infections, particularly for people without symptoms emphasising the need for rapid, sensitive, accurate and portable tests.

Read article

Antimicrobial Resistance crisis needs better diagnostics

Tue, February 22nd 2022

“Better, faster diagnostics will be central to tackling Antimicrobial Resistance in the future,” said ProtonDx Founder & Director, Asst Professor Jesus Rodriguez-Manzano, at a recent FORUM event organised by the Academy of Medical Sciences

Read article

ProtonDx CEO award for inspiration

Mon, December 20th 2021

ProtonDx CEO, Professor Pantelis Georgiou has won an award for his inspirational work from his colleagues in the Department of Electrical and Electronic Engineering, Imperial College London

Read article

Imperial Biomedical hub officially opened

Mon, December 6th 2021

ProtonDx is privileged to have secured office space in the prestigious Translation and Innovation Hub (IHUB) at White City campus of Imperial College London.

Read article

Best of British recognises ProtonDx

Thu, September 23rd 2021

The work of the ProtonDx team has been recognized in Best of British a government publication produced jointly with Malaria NO MORE.

Read article

ProtonDx CEO appointed Professor of Biomedical Electronics

Wed, September 22nd 2021

CEO of ProtonDx, Dr Pantelis Georgiou, was promoted to Professor of Biomedical Electronics in the annual promotion round at Imperial College London, one of only six to achieve this accolade this year.  

Read article